A Case Report of Graves' Disease Induced by the Anti-Human Programmed Cell Death-1 Monoclonal Antibody Pembrolizumab in a Bladder Cancer Patient

Immune checkpoint inhibitors, such as anti-programmed cell death-1 (anti-PD-1), have been widely used in the treatment of malignancies. However, these drugs can cause immune-related adverse events resembling autoimmune diseases. There are some reports of Graves' disease (GD) induced by anti-cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yajima, Ken, Akise, Yushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854234/
https://www.ncbi.nlm.nih.gov/pubmed/31772785
http://dx.doi.org/10.1155/2019/2314032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854234/
https://www.ncbi.nlm.nih.gov/pubmed/31772785
http://dx.doi.org/10.1155/2019/2314032

Ejemplares similares